RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 122 filers reported holding RIGEL PHARMACEUTICALS INC in Q3 2016. The put-call ratio across all filers is 0.31 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $181,000 | -35.1% | 76,149 | 0.0% | 0.00% | – |
Q3 2016 | $279,000 | +64.1% | 76,149 | 0.0% | 0.00% | – |
Q2 2016 | $170,000 | +7.6% | 76,149 | 0.0% | 0.00% | – |
Q1 2016 | $158,000 | -31.6% | 76,149 | 0.0% | 0.00% | – |
Q4 2015 | $231,000 | +29.8% | 76,149 | +5.7% | 0.00% | – |
Q3 2015 | $178,000 | -22.9% | 72,065 | 0.0% | 0.00% | – |
Q2 2015 | $231,000 | +122.1% | 72,065 | +147.7% | 0.00% | – |
Q1 2015 | $104,000 | -79.9% | 29,091 | -87.2% | 0.00% | – |
Q4 2014 | $517,000 | -55.4% | 227,922 | -61.9% | 0.00% | -100.0% |
Q3 2014 | $1,160,000 | -44.6% | 598,253 | +3.8% | 0.00% | 0.0% |
Q2 2014 | $2,092,000 | +227.4% | 576,293 | +249.7% | 0.00% | – |
Q1 2014 | $639,000 | +34.8% | 164,781 | -0.8% | 0.00% | – |
Q4 2013 | $474,000 | -20.3% | 166,152 | 0.0% | 0.00% | – |
Q3 2013 | $595,000 | +26.6% | 166,152 | +18.3% | 0.00% | – |
Q2 2013 | $470,000 | – | 140,480 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CM Management, LLC | 1,500,000 | $1,620,000 | 1.72% |
Soleus Capital Management, L.P. | 14,803,015 | $15,987,256 | 1.48% |
ARMISTICE CAPITAL, LLC | 17,136,000 | $18,506,880 | 0.28% |
SPHERA FUNDS MANAGEMENT LTD. | 1,228,126 | $1,326,376 | 0.24% |
GSA CAPITAL PARTNERS LLP | 971,441 | $1,049 | 0.09% |
NJ State Employees Deferred Compensation Plan | 200,000 | $216,000 | 0.03% |
Providence Wealth Advisors, LLC | 27,500 | $29,013 | 0.03% |
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 1,151,765 | $1,243,906 | 0.03% |
XTX Topco Ltd | 164,238 | $177,377 | 0.03% |
JACOBS LEVY EQUITY MANAGEMENT, INC | 3,369,076 | $3,638,602 | 0.02% |